Business
Paradigm (ASX:PAR) share price shoots 30% higher on FDA update
Image source: Getty Images
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has returned from its trading halt and is charging higher on Wednesday.
At the time of writing, the biopharmaceutical company’s shares are up 30% to $2.69.
Why is the Paradigm share price charging higher?
…
Continue Reading
-
Business14 hours ago10 ASX shares to buy after the market selloff
-
General18 hours ago‘We are here for you’: PM to bring help to flood zones
-
General16 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General13 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains